MY112414A - Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals - Google Patents
Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticalsInfo
- Publication number
- MY112414A MY112414A MYPI94002896A MYPI19942896A MY112414A MY 112414 A MY112414 A MY 112414A MY PI94002896 A MYPI94002896 A MY PI94002896A MY PI19942896 A MYPI19942896 A MY PI19942896A MY 112414 A MY112414 A MY 112414A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceuticals
- preparation
- substituted heterocyclic
- heterocyclic carboxamide
- carboxamide esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
THE INVENTION RELATES TO COMPOUNDS OF THE FORMULA I, FORMULA 1 TO A PROCESS FOR THEIR PREPARATION AND TO THEIR USE AS PHARMACEUTICALS. THE COMPOUNDS ARE EMPLOYED, IN PARTICULAR, AS ESTER PRODRUGS OF PROLYL HYDROXYLASE INHIBITORS FOR INHIBITING COLLAGEN BIOSYNTHESIS AND AS FIBRO-SUPPRESSIVE AGENTS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4337270A DE4337270A1 (en) | 1993-11-02 | 1993-11-02 | Substituted heterocyclic carboxamidoesters, their preparation and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
MY112414A true MY112414A (en) | 2001-06-30 |
Family
ID=6501545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI94002896A MY112414A (en) | 1993-11-02 | 1994-10-31 | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE4337270A1 (en) |
MY (1) | MY112414A (en) |
ZA (1) | ZA948579B (en) |
-
1993
- 1993-11-02 DE DE4337270A patent/DE4337270A1/en not_active Withdrawn
-
1994
- 1994-10-31 MY MYPI94002896A patent/MY112414A/en unknown
- 1994-11-01 ZA ZA948579A patent/ZA948579B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA948579B (en) | 1995-06-27 |
DE4337270A1 (en) | 1995-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH31264A (en) | Substituted heterocyclic carboxamide esters, and their use as pharmaceuticals. | |
MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
RU94045141A (en) | Heterocyclic derivatives of carboxylic acid and their salts and pharmaceutical composition showing antifibrotic or prolylhydroxylase-inhibiting activity or collagen biosynthesis inhibition | |
HUP9900816A3 (en) | Use of piperidine carboxylic acid derivatives for producing pharmaceutical compositions as inhibitors of rotamase enzyme activity | |
EP0693083A4 (en) | Alpha-ketoamide derivatives as inhibitors of thrombosis | |
DE69637380D1 (en) | Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen | |
TW225534B (en) | ||
HUP9901752A3 (en) | Piperidine carboxylic acid derivatives as rotamase enzyme activity inhibitors and use of them for producing pharmaceutical compositions suitable for treating neurological activity | |
AU5683296A (en) | N-benzylindol-3-yl propanic acid derivatives as cyclooxygena se-2 inhibitors | |
PL318595A1 (en) | Derivatives of phenyloacetic acid, method of and intermediate products for obtaining them and agents containing such derivatives | |
PT1023267E (en) | PYRIDYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AU6570186A (en) | Novel pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity and synthesis and use thereof | |
AU9066498A (en) | Substituted 6-alkylphenanthridines | |
EP0658585A3 (en) | Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants. | |
MY104354A (en) | Non-peptidic renin inhibitors | |
MY112414A (en) | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals | |
AU6306190A (en) | Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis | |
CA2208032A1 (en) | Substituted amidinonaphthyl ester derivative | |
NZ334404A (en) | L-trans-2-amino-4-(acetamidoethoxy)-3-butenoic acid also known as N-acetyl aminoethoxyvinylglycine and its use as an ethylene biosynthesis inhibitor | |
AU2806595A (en) | Pyridonecarboxylic acid derivative, ester thereof, salt thereof, and intermediate for synthesis of these compounds |